Ulpiano Jiménez
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 2
- Oncology 3
- Lung Cancer Research Studies 3
- Co-authors
- Rafael Rosell (4 shared papers)Carlos Camps (4 shared papers)Jose Luis González Larriba (2 shared papers)Dolores Isla (4 shared papers)José Javier Sánchez (2 shared papers)Mariano Provencio (3 shared papers)Alfredo Carrato (1 shared paper)Catalina Vadell (2 shared papers)
- Journals
- European Journal of Cancer (2 papers)Journal of Thoracic Oncology (2 papers)Journal of Clinical Oncology (1 paper)Clinical & Translational Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- SpainUnited States
In The Last Decade
Ulpiano Jiménez
10 papers receiving 5.1k citations
Ulpiano Jiménez's Hit Papers
Peers
Comparison fields: 5 of 87
- Pulmonary and Respiratory Medicine 3.9k
- Oncology 2.3k
- Cancer Research 808
- Molecular Biology 1.0k
- Pathology and Forensic Medicine 196
Countries citing papers authored by Ulpiano Jiménez
This map shows the geographic impact of Ulpiano Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulpiano Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulpiano Jiménez more than expected).
Fields of papers citing papers by Ulpiano Jiménez
This network shows the impact of papers produced by Ulpiano Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulpiano Jiménez. The network helps show where Ulpiano Jiménez may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulpiano Jiménez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Hit paper breakdown → | 2012 | 4725 |
| 2 | 2003 | 160 | |
| 3 | 2009 | 132 | |
| 4 | 2010 | 80 | |
| 5 | 2011 | 65 | |
| 6 | 2012 | 19 | |
| 7 | 2001 | 4 | |
| 8 | 2007 | 1 | |
| 9 | 2007 | 1 | |
| 10 | 1995 | 1 |
About Ulpiano Jiménez
Ulpiano Jiménez is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biotechnology, Cancer Research and Cell Biology, having authored 10 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Microtubule and mitosis dynamics (1 paper), Cancer Genomics and Diagnostics (1 paper), Urinary and Genital Oncology Studies (1 paper), Cancer Research and Treatments (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.9k citations), Oncology (2.3k citations), Cancer Research (808 citations), Molecular Biology (1.0k citations) and Pathology and Forensic Medicine (196 citations). Ulpiano Jiménez has collaborated with scholars based in Spain and United States. Frequent co-authors include Rafael Rosell, Carlos Camps, Jose Luis González Larriba, Dolores Isla, José Javier Sánchez, Mariano Provencio, Alfredo Carrato, Catalina Vadell, Vincente Alberola and Isabel Bover. Their work appears in journals such as European Journal of Cancer, Journal of Thoracic Oncology, Journal of Clinical Oncology, Clinical & Translational Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.